ClinicalTrials.Veeva

Menu

Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation (NOTION-3)

T

Thomas Engstrom

Status

Active, not recruiting

Conditions

Coronary Artery Disease
Aortic Valve Stenosis
PCI
TAVI

Treatments

Procedure: PCI

Study type

Interventional

Funder types

Other

Identifiers

NCT03058627
H-16039929

Details and patient eligibility

About

The aim of this study is to evaluate the effect of routine FFR-guided complete revascularization with PCI compared to conservative management in patients with concomitant coronary artery disease who are undergoing TAVI.

Enrollment

454 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years
  2. Severe aortic valve stenosis and selected for TAVI by a multi-disciplinary Heart Team
  3. At least one stenosis with FFR ≤ 0.80 or diameter stenosis > 90% in a coronary artery ≥ 2.5 mm in diameter

Exclusion criteria

  1. Life expectancy < 1 year due to other severe non-cardiac disease
  2. Severe renal failure with estimated glomerular filtration rate < 20 ml/min
  3. No PCI-eligible coronary artery stenosis, but rotablation is allowed
  4. Admitted with a new acute coronary syndrome (ST-elevation myocardial infarction (STEMI) or non-STEMI) within 14 days
  5. Significant stenosis in left main stenosis or ostial left anterior descending artery (LAD) + ostial left circumflex artery (LCx))
  6. Only stenoses with thrombolysis in myocardial infarction grad < 3
  7. Potential pregnancy
  8. Known allergy towards P2Y12 receptor antagonists, heparin or contrast medium
  9. More than one chronic total occlusion (CTO)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

454 participants in 2 patient groups

TAVI only
No Intervention group
Description:
TAVI is performed according to current guidelines and the choice of valve prosthesis is at the operators' discretion.
TAVI + FFR-guided complete revascularization
Experimental group
Description:
TAVI is performed according to current guidelines and the choice of transcatheter heart valve is at the operators' discretion. PCI is performed in any suitable lesion with diameter stenosis \> 90% or FFR ≤ 0.80 in vessels ≥ 2.5 mm in diameter .
Treatment:
Procedure: PCI

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems